Facebook
Twitter
LinkedIn
Forward- ANNE RIFLEMAN
- Rachael Alexander
Series Overview
This is a weekly case conference to review and discuss complex breast cancer cases. It is attended by the multi-disciplinary team which includes breast surgeons, medical oncologists, radiation oncologists, pathologists, radiologists, genetic counselors, Social Work Navigators APP's, nurses, fellows, residents and research staff. The team reviews individual cases and discusses plan of care and recommendations for treatment.
Target Audience
- Nurses
- Nurse Practitioners
- Physicians
- Physician Assistants
- Residents/Fellows
- Social Workers
- Students
Planning Committee
| Lee Wilke, MD, Chair | Destiny Thao |
| Anne Rifleman, MSM, BSN, RN, Coordinator | Melissa Schuett, RN |
Accreditation
Accreditation Statement
 | In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour. The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
POLICY ON FACULTY AND SPONSOR DISCLOSURE
It is the policy of the University of Wisconsin–Madison ICEP, that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).
Detailed disclosures will be available prior to the start of the activity.
Upon completion of this activity participants will:
- Increase knowledge of the clinical practice of other disciplines and specialties caring for patients with breast cancer
- Improve ability to document appropriate recommendations and clinical decisions in complex breast cancer cases
- Improve interprofessional, multi-disciplinary communication in breast cancer care
- Develop improved and standardized processes for treatment of patients with breast cancer
